Dynamic risk profiling of HCC recurrence after curative intent liver resection

医学 转移 肝内胆管癌 内科学 外科 肿瘤科 癌症
作者
Tommy Ivanics,Carla Perez,Marco P. A. W. Claasen,Madhukar S. Patel,Gabriela Morgenshtern,Lauren Erdman,Chaya Shwaartz,Luckshi Rajendran,Grainne M. O’Kane,Bettina E. Hansen,Sean P. Cleary,Gonzalo Sapisochín
出处
期刊:Hepatology [Lippincott Williams & Wilkins]
卷期号:76 (5): 1291-1301 被引量:54
标识
DOI:10.1002/hep.32411
摘要

BACKGROUND AND AIMS: Following liver resection (LR) for HCC, the likelihood of survival is dynamic, in that multiple recurrences and/or metastases are possible, each having variable impacts on outcomes. We sought to evaluate the natural progression, pattern, and timing of various disease states after LR for HCC using multistate modeling and to create a practical calculator to provide prognostic information for patients and clinicians. APPROACH AND RESULTS: Adult patients undergoing LR for HCC between January 2000 and December 2018 were retrospectively identified at a single center. Multistate analysis modeled post-LR tumor progression by describing transitions between distinct disease states. In this model, the states included surgery, intrahepatic recurrence (first, second, third, fourth, fifth), distant metastasis with or without intrahepatic recurrence, and death. Of the 486 patients included, 169 (34.8%) remained recurrence-free, 205 (42.2%) developed intrahepatic recurrence, 80 (16.5%) developed distant metastasis, and 32 (7%) died. For an average patient having undergone LR, there was a 33.1% chance of remaining disease-free, a 31.0% chance of at least one intrahepatic recurrence, a 16.3% chance of distant metastasis, and a 19.8% chance of death within the first 60 months post-LR. The transition probability from surgery to first intrahepatic recurrence, without a subsequent state transition, increased from 3% (3 months) to 17.4% (30 months) and 17.2% (60 months). Factors that could modify these probabilities included tumor size, satellite lesions, and microvascular invasion. The online multistate model calculator can be found on https://multistatehcc.shinyapps.io/home/. CONCLUSIONS: In contrast to standard single time-to-event estimates, multistate modeling provides more realistic prognostication of outcomes after LR for HCC by taking into account many postoperative disease states and transitions between them. Our multistate modeling calculator can provide meaningful data to guide the management of patients undergoing postoperative surveillance and therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
Dr-xu0002发布了新的文献求助10
1秒前
wanci应助武雨寒采纳,获得10
1秒前
zhaoyaoshi完成签到 ,获得积分10
3秒前
4秒前
CRUSADER应助cnspower采纳,获得100
4秒前
激昂的含玉完成签到,获得积分20
6秒前
Ava应助迅速翠风采纳,获得10
7秒前
dianeil发布了新的文献求助10
7秒前
青云完成签到,获得积分10
8秒前
涵青夏发布了新的文献求助10
9秒前
MZ完成签到,获得积分0
15秒前
lsl完成签到 ,获得积分10
16秒前
YoungLee完成签到 ,获得积分10
16秒前
nano完成签到 ,获得积分10
17秒前
dianeil完成签到,获得积分10
18秒前
激昂的含玉关注了科研通微信公众号
20秒前
刻苦不弱发布了新的文献求助20
20秒前
WW完成签到 ,获得积分10
21秒前
雨中行远完成签到,获得积分10
25秒前
afterglow完成签到 ,获得积分10
26秒前
科研通AI6.2应助房白凝采纳,获得10
28秒前
wulin314发布了新的文献求助20
30秒前
搜集达人应助宋相甫采纳,获得10
30秒前
36秒前
陈念完成签到,获得积分10
39秒前
39秒前
DJC完成签到,获得积分10
39秒前
李爱国应助涵青夏采纳,获得10
40秒前
任性的思远完成签到 ,获得积分10
40秒前
立青完成签到,获得积分10
41秒前
烂漫的煎饼完成签到 ,获得积分10
42秒前
Shuang完成签到 ,获得积分10
42秒前
刻苦青烟完成签到 ,获得积分10
42秒前
迅速翠风发布了新的文献求助10
42秒前
宋相甫发布了新的文献求助10
45秒前
青黛完成签到 ,获得积分10
45秒前
是小妤呀完成签到 ,获得积分10
46秒前
受不了12345完成签到,获得积分10
46秒前
小张完成签到 ,获得积分10
47秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Health Psychology 600
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
When Is Two-Stage Sample Robust Optimization Asymptotically Optimal? 500
APA handbook of comparative psychology: Basic concepts, methods, neural substrate, and behavior 500
Discerning Saints: Moralization of Intrinsic Motivation and Selective Prosociality at Work 500
Handbuch Trainingswissenschaft – Trainingslehre 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7592560
求助须知:如何正确求助?哪些是违规求助? 9169779
关于积分的说明 19626255
捐赠科研通 7170522
什么是DOI,文献DOI怎么找? 3267520
关于科研通互助平台的介绍 2432371
邀请新用户注册赠送积分活动 2260009